Treatment progress and nutritional assessment for the patients with gastrointestinal neoplasms during perichemotheraputic period

doi:10.3760/cma.j.issn.1673-422X.2013.11.017

Abstract

Abstract: Malnutrition is the common complication for the patients with gastrointestinal neoplasms during perioperative period. Tumor and chemotherapy drugs are the main influencing factors of patients with malnutrition. The correct evaluation of the nutritional status in patients is the basis of individualized nutrition therapy. New evaluation methods and nutritional preparations could more help patients with gastrointestinal neoplasms during perioperative period to maintaining good nutritional status.

Key words: Nutrition assessment, Nutritional support, Gastrointestinal neoplasms

DUAN Ying-Xin, LI Jun-Ling. Treatment progress and nutritional assessment for the patients with gastrointestinal neoplasms during perichemotheraputic period[J]. Journal of International Oncology, 2013, 40(11): 858-861.

References

［1］ Lawrence B, Gustafsson BI, Chan A, et al. The epidemiology of gastroenteropancreatic neuroendocrine tumors. Endocrinol Metab Clin North Am, 2011,40(1):1-18. ［2］Karlsson S, Andersson L, Berglund B. Early assessment of nutritional status in patients scheduled for colorectal cancer surgery. Gastroenterology Nursing, 2009, 32(4):265-270. ［3］Fontes D, Generoso SD, Toulson Davisson Correia MI. Subjective global assessment: a reliable nutritional assessment tool to predict outcomes in critically ill patients. Clin Nutr, 2013，In press. ［4］Wu BW, Yin T, Cao WX, et al. Clinical application of subjective global assessment in Chinese patients with gastrointestinal cancer. World J Gastroenterol, 2009,15(28):3542-3549. ［5］Martin L, Watanabe S, Fainsinger R, et al. Prognostic factors in patients with advanced cancer: use of the patient-generated subjective global assessment in survival prediction. J Clin Oncol, 2010,28(28):4376-4383. ［6］Isenring E, Hill J, Davidson W, et al. Evidence based practice guidelines for the nutritional management of patients receiving radiation therapy. Nutrition & Dietetics, 2008, 65(Suppl 1): S1-S20. ［7］Hill A, Kiss N, Hodgson B, et al. Associations between nutritional status, weight loss, radiotherapy treatment toxicity and treatment outcomes in gastrointestinal cancer patients. Clin Nutr, 2011, 30(1): 92-98. ［8］Gabrielson DK, Scaffidi D, Leung E, et al. Use of an abridged scored patientgenerated subjective global assessment (abPG-SGA) as a nutritional screening tool for cancer patients in an outpatient setting. Nutr Cancer, 2013, 65(2): 234-239. ［9］Velasco C, García E, Rodríguez V, et al. Comparison of four nutritional screening tools to detect nutritional risk in hospitalized patients: a multicentre study. Eur J Clin Nutr, 2011, 65(2): 269-274. ［10］Neelemaat F, Meijers J, Kruizenga H, et al. Comparison of five malnutrition screening tools in one hospital inpatient sample. J Clin Nurs, 2011,20(15-16):2144-2152. ［11］Ling CH, de Craen AJ, Slagboom PE, et al. Accuracy of direct segmental multi-frequency bioimpedance analysis in the assessment of total body and segmental body composition in middle-aged adult population. Clin Nutr, 2011,30(5):610-615. ［12］Andreoli A, De Lorenzo A, Cadeddu F, et al. New trends in nutritional status assessment of cancer patients. Eur Rev Med Pharmacol Sci, 2011,15(5):469-480. ［13］Xue H, Sawyer MB, Wischmeyer PE, et al. Nutrition modulation of gastrointestinal toxicity related to cancer chemotherapy: from preclinical findings to clinical strategy. JPEN J Parenter Enteral Nutr, 2011, 35(1): 74-90. ［14］Bozzetti F, Arends J, Lundholm K, et al. ESPEN Guidelines on Parenteral Nutrition:nonsurgical oncology. Clin Nutr,2009, 28(4): 445-454. ［15］Mitchell J, Jatoi A. Parenteral nutrition in patients with advanced cancer: merging perspectives from the patient and healthcare provider. Semin Oncol, 2011,38(3):439-442. ［16］Marik PE, Flemmer M. Immunonutrition in the surgical patient. Minerva Anestesiol, 2012,78(3):336-342. ［17］Paccagnella A, Morassutti I, Rosti G. Nutritional intervention for improving treatment tolerance in cancer patients. Curr Opin Oncol, 2011,23(4):322-330. ［18］Nguyen NQ, Besanko LK, Burgstad C, et al. Delayed enteral feeding impairs intestinal carbohydrate absorption in critically ill patients. Crit Care Med, 2012,40(1):50-54. ［19］Sippel TR, White J, Nag K, et al. Neutrophil degranulation and immunosuppression in patients with GBM: restoration of cellular immune function by targeting arginase Ⅰ. Clin Cancer Res, 2011,17(22):6992-7002. ［20］Kim H. Glutamine as an immunonutrient. Yonsei Med J, 2011,52(6):892-897. ［21］Serini S, Piccioni E, Merendino N, et al. Dietary polyunsaturated fatty acids as inducers of apoptosis: implications for cancer. Apoptosis, 2009,14(2):135-152. ［22］Gee AC, Kiraly L, McCarthy MS, et al. Nutrition support and therapy in patients with head and neck squamous cell carcinomas. Curr Gastroenterol Rep, 2012,14(4):349-355. ［23］Santarpia L, Contaldo F, Pasanisi F. Nutritional screening and early treatment of malnutrition in cancer patients. J Cachexia Sarcopenia Muscle, 2011, 2(1): 27-35. ［24］Akamizu T, Kangawa K. Ghrelin for cachexia. J Cachexia Sarcopenia Muscle, 2010, 1(2): 169-176.

[1]	Xue Ruiqi, Li Hongwei, Zhang Xiaqin, Song Xin, Peng Hua, Zhou Wei, Zhang Changcheng. Association of the prognostic nutrition index with overall survival time of the patients with brain metastases of lung adenocarcinoma [J]. Journal of International Oncology, 2018, 45(6): 341-346.
[2]	Gao Guangchao, Chen Zongyan, Ji Yanbo, Sun Feifei, Dai Beibei, Yu Xiaoxia, Xu Cuiping. Correlations between cancer related fatigue and serum inflammatory factors and hypothalamus-pituitary-adrenal axis in patients with gastrointestinal cancer [J]. Journal of International Oncology, 2017, 44(7): 508-511.
[3]	ZHAO Yi, YAN Shan-Jun, WANG Qi-Zhi. Expression and mechanism of UCA1 in gastrointestinal tumors [J]. Journal of International Oncology, 2017, 44(2): 142-144.
[4]	Huang Yan, Cheng Dan, Yang Jiyuan. Targeted therapies for gastrointestinal cancer [J]. Journal of International Oncology, 2017, 44(1): 71-74.
[5]	ZHENG Tao, LI Tao, WU Jing-Bo. Status treatment of the Ⅳ stage esophageal cancer [J]. Journal of International Oncology, 2015, 42(3): 214-217.
[6]	ZHU Yu-Ping, LI De-Chuan, LIU Zhuo. Research progress of gastrointestinal stromal tumor [J]. Journal of International Oncology, 2014, 41(6): 447-450.
[7]	WANG Qian-Qian, XU Chao. Gastrointestinal malignancies and cardiovascular diseases [J]. Journal of International Oncology, 2013, 40(8): 692-695.
[8]	JU Feng, ZUO Jun-Bo, XIA Jia-Zeng. Small interfering RNA in gastrointestinal cancer [J]. Journal of International Oncology, 2012, 39(7): 538-540.